A Clinical Study of the ACRYSOF® IQ Extended Depth of Focus Intraocular Lens (IOL)

NACompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

October 11, 2017

Primary Completion Date

October 16, 2018

Study Completion Date

October 16, 2018

Conditions
Cataract
Interventions
DEVICE

ACRYSOF® IQ Extended Depth of Focus IOL

Implantable IOL intending to extend the depth of focus and provide continuous functional vision from distance to near while maintaining distance vision and a visual disturbance profile comparable to a monofocal IOL.

DEVICE

ACRYSOF® IQ Monofocal IOL

Monofocal IOL implanted for long-term use over the lifetime of the pseudophakic subject

PROCEDURE

Cataract surgery

IOL bilateral implantation

Trial Locations (11)

15122

Alcon Investigative Site, West Mifflin

17810

Alcon Investigative Site, Allenwood

18704

Alcon Investigative Site, Kingston

30501

Alcon Investigative Site, Gainesville

33870

Alcon Investigative Site, Sebring

34209

Alcon Investigative Site, Bradenton

35213

Alcon Investigative Site, Birmingham

45242

Alcon Investigative Site, Cincinnati

57108

Alcon Investigative Site, Sioux Falls

61201

Alcon Investigative Site, Rock Island

80528

Alcon Investigative Site, Fort Collins

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT03274986 - A Clinical Study of the ACRYSOF® IQ Extended Depth of Focus Intraocular Lens (IOL) | Biotech Hunter | Biotech Hunter